HOPENT Red light therapeutic instrument
brand name :
fob price :
payment terms :
100 Stations / case
Production Capacity :
place of origin :
Manag Certifica :
The incidence rate of allergic rhinitis is about 50%,Allergens come from natural pollen, pet hair, chemicals, cold air, car exhaust and so on, And increased year by year at an alarming rate, Long term chronic recurrent attacks will lead to complications such as sinusitis, otitis media, headache, dark circles, inability to concentrate, irritability, decreased learning ability and so on.
It uses 630 nm wavelength low-energy narrow-band cold red light with world patent to irradiate the inflammatory area of nasal mucosa, The treatment scheme without any toxic and side effects complies with the standards of the International Radiation Protection Association (IRPA) and the international medical device safety test (IEC).
Comparison before and after treatment
It uses 630nm low-energy narrow-band red light technology (light energy therapy) to inhibit the release of histamine, oxygen generation reaction and the opening of calcium channels, and completely relieve the symptoms of nasal congestion, runny nose and sneezing.
Usage: 3 times a day, 4.5 minutes each time, and each course of treatment is 10 days.
Clinical application scope:
1. Inhibit the occurrence of allergic rhinitis
2. Treatment of acute and chronic rhinitis
3. Effective prevention of nasal polyps
4. Promote the repair of nasal mucositis and postoperative wound
It has been registered and certified by China nmpa, the United Kingdom, Germany, France, South Africa, Canada and other countries, EU CE0473, ISO13485 and ISO9001 system certification, It has been authorized and protected by invention patents and appearance patents from Britain, Europe, Canada and other countries around the world, and has sold well in more than 100 countries and regions around the world.